These findings illustrate that OXTR has protective effects in PPD by inhibiting NLRP3 inflammasome activation and provides a new strategy for targeting lncRNA Gm14205 in the pathogenesis of PPD. The gene discussed is OXTR; the disease is progressive pseudorheumatoid arthropathy of childhood.